{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:52:45Z","timestamp":1792093965853,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejmech.2023.115166","type":"journal-article","created":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T14:50:34Z","timestamp":1675003834000},"page":"115166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["PKM2\/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolism"],"prefix":"10.1016","volume":"249","author":[{"given":"Hongyan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minkai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongling","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongming","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinliang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8647-1158","authenticated-orcid":false,"given":"Yonghua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejmech.2023.115166_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2023.115166_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41467-020-20162-8","article-title":"Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2023.115166_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41419-017-0063-y","article-title":"Cell death-based treatment of lung adenocarcinoma","volume":"9","author":"Denisenko","year":"2018","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.ejmech.2023.115166_bib4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nm.3854","article-title":"Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M","volume":"21","author":"Thress","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2023.115166_bib5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2023.115166_bib6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115166_bib7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2023.115166_bib8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature06734","article-title":"The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumor growth","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115166_bib9","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.3892\/ol.2016.4168","article-title":"PKM2 and cancer: the function of PKM2 beyond glycolysis","volume":"11","author":"Dong","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejmech.2023.115166_bib10","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.3390\/ijms20225622","article-title":"Knockdown of pyruvate kinase M2 inhibits cell proliferation, metabolism, and migration in renal cell carcinoma","volume":"20","author":"Dey","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115166_bib11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nbt.2285","article-title":"Therapeutic targets in cancer cell metabolism and autophagy","volume":"30","author":"Cheong","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2023.115166_bib12","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/srep16082","article-title":"Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep.-UK"},{"key":"10.1016\/j.ejmech.2023.115166_bib13","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1038\/onc.2015.397","article-title":"Cytosolic PKM2 stabilizes mutant EGFR protein expression through regulating HSP90-EGFR association","volume":"35","author":"Yang","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2023.115166_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature10598","article-title":"Nuclear PKM2 regulates \u03b2-catenin transactivation upon EGFR activation","volume":"480","author":"Yang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115166_bib15","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1182\/blood-2018-99-113960","article-title":"PKM2 mediates chronic myeloid leukemia imatinib resistance by regulating glycolysis energy metabolism","volume":"132","author":"Tong","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2023.115166_bib16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.chembiol.2012.07.021","article-title":"Small molecular activation of PKM2 in cancer cells induces serine auxotrophy","volume":"19","author":"Kung","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115166_bib17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.molcel.2014.09.026","article-title":"A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth","volume":"56","author":"Schell","year":"2014","journal-title":"Mol. Cell."},{"key":"10.1016\/j.ejmech.2023.115166_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molcel.2020.09.018","article-title":"Phosphorylation of PDHA by AMPK drives TCA cycle to promote cancer metastasis","volume":"80","author":"Cai","year":"2020","journal-title":"Mol. Cell."},{"key":"10.1016\/j.ejmech.2023.115166_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/neo.04373","article-title":"Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non-small cell lung cancer and tumor-associated stroma","volume":"7","author":"Koukourakis","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejmech.2023.115166_bib20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ijc.31812","article-title":"Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase","volume":"144","author":"Golias","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2023.115166_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2018.09.016","article-title":"Inhibition of pyruvate dehydrogenase kinase 1 enhances the anti-cancer effect of EGFR tyrosine kinase inhibitors in non-small cell lung cancer","volume":"838","author":"Yang","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115166_bib22","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1158\/0008-5472.CAN-15-1023","article-title":"JX06 selectively inhibits pyruvate dehydrogenase kinase PDK1 by a covalent cysteine modification","volume":"75","author":"Sun","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115166_bib23","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1021\/acs.jmedchem.6b01245","article-title":"Development of the first generation of disulfide-based subtype-selective and potent covalent pyruvate dehydrogenase kinase 1 (PDK1) inhibitors","volume":"60","author":"Liu","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115166_bib24","first-page":"1067","article-title":"Comparative study on enantiomeric excess of main akannin\/shikonin derivatives isolated from the roots of three endemic Boraginaceae plants in China, Biomed","volume":"25","author":"Zhou","year":"2011","journal-title":"Chromatography"},{"key":"10.1016\/j.ejmech.2023.115166_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M pro from COVID-19 virus and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115166_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.canlet.2008.09.029","article-title":"Naturally-occurring shikonin analogues-A class of necroptotic inducers that circumvent cancer drug resistance","volume":"274","author":"Xuan","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2023.115166_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.lfs.2018.05.012","article-title":"Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2\/stat3\/cyclin D1 signal pathway","volume":"204","author":"Tang","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2023.115166_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13020-020-00305-1","article-title":"Shikonin and 4-hydroxytamoxifen synergistically inhibit the proliferation of breast cancer cells through activating apoptosis signaling pathway in vitro and in vivo","volume":"15","author":"Lin","year":"2020","journal-title":"Chin Med-UK"},{"key":"10.1016\/j.ejmech.2023.115166_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejmech.2017.12.019","article-title":"Design and characterization of \u03b1-lipoic acyl shikonin ester twin drugs as tubulin and PDK1 dual inhibitors","volume":"144","author":"Lin","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115166_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1073\/pnas.1311249111","article-title":"JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1\u03b1 mediated glucose metabolism","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2023.115166_bib31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1084\/jem.20111487","article-title":"Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression","volume":"209","author":"Goldberg","year":"2012","journal-title":"J. Exp. Med."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423000818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423000818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T16:14:50Z","timestamp":1737303290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423000818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":31,"alternative-id":["S0223523423000818"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115166","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PKM2\/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolism","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115166"}}